Omacor (Omega-3-Acid Ethyl Esters 90)

Omega-3-Acid Ethyl Esters, the active ingredient in Omacor, is a omega-3 fatty acid (prescription) presented as a 90 mg oral capsule for oral use. It is prescribed to help manage elevated triglyceride levels in adults with primary hypertriglyceridaemia. GNH USA supplies Omacor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omacor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omacor is a prescription omega‑3 fatty acid used to modify lipid profiles, particularly in patients with high triglyceride concentrations. - Primary hypertriglyceridaemia: lowers the risk of pancreatitis by reducing triglyceride levels. - Mixed dyslipidaemia: contributes to overall improvement of lipid parameters including LDL‑C and non‑HDL cholesterol. - Adjunct to diet and lifestyle therapy: supports the reduction of triglycerides when dietary measures are insufficient.

Adverse reactions to Omacor are generally mild and dose‑dependent.

Common Side Effects: - Fish‑like aftertaste - Indigestion or dyspepsia - Nausea - Diarrhoea - Mild abdominal discomfort - Increased belching

Serious or Rare Side Effects: - Acute pancreatitis - Severe allergic reactions (anaphylaxis, angio‑edema) - Elevated liver enzymes (ALT/AST) - Bleeding tendencies, especially when combined with anticoagulants - Atrial A   

Omacor should be used with caution: -  C   a  

   t